108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
Genome editing of graft-derived T-cells for post-transplant immunotherapy
#4202SINGLE CELL CLONING APPROACHES FOR BIOLOGICAL STUDIES
#4203METHODS AND COMPOSITIONS TO IDENTIFY NOVEL CRISPR SYSTEMS
#4204Compositions and methods for genomic editing by insertion of donor polynucleotides
#4205Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies
#4206METHODS OF TREATING CANCER
#4207Compositions and methods for modulating gene expression
#4208Compositions and methods for treating disorders of genomic imprinting
#4209METHOD FOR MODIFYING GENOME SEQUENCE TO INTRODUCE SPECIFIC MUTATION TO TARGETED DNA SEQUENCE BY BASE-REMOVAL REACTION, AND MOLECULAR COMPLEX USED THEREIN
#4210SINGLE BASE EDITING TOOLS WITH PRECISE ACCURACY
#4211Modified cascade ribonucleoproteins and uses thereof
#4212Using proteases to control restriction enzyme activity
#4213Transposase polypeptides and uses thereof
#4214MAD nucleases
#4215METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS
#4216Method for removing and/or detecting nucleic acids having mismatched nucleotides
#4217Optimized plant CRISPR/CPF1 systems
#4218Single-vector type I vectors
#4219NOVEL CAS12B ENZYMES AND SYSTEMS
#4220Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)
#4221COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES
#4222CRISPR therapy
#4223MRNA driven expression of RNA editors for treatment of pathologies
#4224ENRICHMENT OF GENOME-EDITED CELLS
#4225METHOD FOR SCREENING AND IDENTIFYING FUNCTIONAL LNCRNAS
#4226Targeted Critical Fluid Nanoparticles Platform for Delivery of Nucleic Acids for Treatment of HIV-1 and Other Diseases
#4227Fusion proteins for base editing
#4228CRISPR/Cas fusion proteins and systems
#4229Polypeptides
#4230CRISPR-cas systems for genome editing
#4231Modified CAS9 protein, and use thereof
#4232Enhanced immune effector cells and use thereof
#4233Detergent composition
#4234Sequence specific antimicrobials
#4235FACTOR VIII OR FACTOR IX GENE KNOCKOUT RABBIT, METHOD FOR PREPARING SAME AND USE THEREOF
#4236CRISPR logic circuits for safer and controllable gene therapies
#4237Compositions and methods to treat cancer
#4238METHODS FOR TREATING SICKLE CELL DISEASE
#4239Compositions and methods for disrupting the molecular mechanisms associated with mitochondrial dysfunction and neurodegenerative disease
#4240METHODS AND COMPOSITIONS FOR INDUCING TUMOR CELL DEATH
#4241Engineered enzymes
#4242NOVEL CRISPR ENZYMES AND SYSTEMS
#4243CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therapy of Inner Ear
#4244HAEMATOPOIETIC STEM CELL TREATMENT
#4245Method for producing lysine by utilizing adsorption and immobilized fermentation of recombinant corynebacterium glutamicum
#4246Methods and means for genetic alteration of genomes utilizing designer DNA recombining enzymes
#4247Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
#4248COMPOSITIONS AND METHODS FOR RNA-TEMPLATED EDITING IN PLANTS
#4249Optimized CRISPR-Cas nucleases and base editors and methods of use thereof
#4250Methods for increasing observed editing in bacteria
#4251Gene editing methods with increased knock-in efficiency
#4252Chimeric polypeptides having targeted binding specificity
#4253Method for Site-Specific Mutagenesis of Medicago Sativa Genes by Using CRISPR/Cas9 System
#4254COMPOSITIONS AND METHODS FOR MODIFYING REGULATORY T CELLS
#4255Sequencing-based proteomics
#4256DNA damage response signature guided rational design of CRISPR-based systems and therapies
#4257CBLB endonuclease variants, compositions, and methods of use
#4258Artificially manipulated immune cell
#4259PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS, PARTICULARLY HIV
#4260DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES
#4261METHODS OF MANUFACTURING CAR-T CELLS
#4262COMPOSITIONS AND METHODS FOR DELIVERY OF RNA TO A CELL
#4263MODIFIED GUIDE RNAS, CRISPR-RIBONUCLEOTPROTEIN COMPLEXES AND METHODS OF USE
#4264NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF
#4265Compositions and Methods for Multiplexed Genome Editing and Screening
#4266CRISPR-Cas systems for genome editing
#4267RNA silencing nanozymes
#4268CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#4269Nucleases and methods for making and using them
#4270ANTI-HBV COMBINATION THERAPIES INVOLVING SPECIFIC ENDONUCLEASES
#4271MANUFACTURING PROCESS FOR MAKING T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS
#4272COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
#4273RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF
#4274Increasing specificity for RNA-guided genome editing
#4275SYSTEMS AND METHODS FOR PLANT GENOME EDITING USING CAS 12a ORTHOLOGS
#4276Compositions and methods for RNA-encoded DNA-replacement of alleles
#4277BACTERIAL DEFENSE SYSTEMS AND METHODS OF IDENTIFYING THEREOF
#4278METHODS OF GENE THERAPY
#4279TYPE V CRISPR-CAS BASE EDITORS AND METHODS OF USE THEREOF
#4280COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA
#4281Compositions and Methods for Enhancement of Homology-Directed Repair Mediated Precise Gene Editing by Programming DNA Repair with a Single RNA-Guided Endonuclease
#4282Gene Editing System and Gene Editing Method
#4283Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
#4284Method to inactivate a mutant allele of an gene
#4285SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING
#4286Regulation of CRISPR-associated rossman fold (CARF) domain containing proteins by oligoadenylates
#4287CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4288METHOD AND COMPOSITION FOR GENERATING BASAL FOREBRAIN CHOLINERGIC NEURONS (BFCNs)
#4289Transgenic mouse for aglycosylated antibody production and use of aglycosylated antibody produced therefrom
#4290COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
#4291Method for removing genetic linkage in a plant
#4292Mammalian cells for producing a secreted protein
#4293METHODS FOR THE IN VIVO PRODUCTION OF SINGLE STRANDED DNA AND USES THEREOF
#4294Crispr DNA targeting enzymes and systems
#4295Optimized small guide RNAs and methods of use
#4296A YEAST TWO-HYBRID RNA-PROTEIN INTERACTION SYSTEM BASED ON CATALYTICALLY INACTIVATED CRISPR-DCAS9
#4297Modified double-stranded donor templates
#4298Cas9-based transcription modulation systems
#4299METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS
#4300SYSTEMS AND METHODS FOR MODULATING CHROMOSOMAL REARRANGEMENTS
#4301Universal donor cells
#4302Method for creating new germplasm of male sterile crop by gene editing and application thereof
#4303THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES
#4304IN VITRO SYNTHESIS METHOD FOR SGRNA AND KIT THEREOF
#4305Tyrosol-producing recombinant and construction method and application thereof
#4306Suppression of pain by gene editing
#4307Variants of CAS12A nucleases and methods of making and use thereof
#4308ENHANCED BCL11A RNP / CRISPR DELIVERY & EDITING USING A 3XNLS-CAS9
#4309CRISPR/Cas9-Mediated Exon-Skipping Approach for USH2A-Associated Usher Syndrome
#4310Systems and methods for increasing efficiency of genome editing
#4311COMPOSITIONS AND METHODS FOR MULTIPLEXED TUMOR VACCINATION WITH ENDOGENOUS GENE ACTIVATION
#4312Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene
#4313CRISPR EFFECTOR SYSTEM BASED MULTIPLEX DIAGNOSTICS
#4314Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4315Carboxylated nanodiamond-mediated CRISPR-CAS9 delivery system
#4316Systems, methods, and compositions for correction of frameshift mutations
#4317FUNCTIONAL GENOMICS USING CRISPR-CAS SYSTEMS, COMPOSITIONS, METHODS, SCREENS AND APPLICATIONS THEREOF
#4318Automated cell processing methods, modules, instruments, and systems
#4319NON-COVALENT SYSTEMS AND METHODS FOR DNA EDITING
#4320Materials and methods for engineering cells and uses thereof in immuno-oncology
#4321PHENOTYPIC READOUT FOR EDITED SEQUENCES IN LIVE CELLS IN AUTOMATED INSTRUMENTATION
#4322Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
#4323RNA-guided systems for probing and mapping of nucleic acids
#4324Programmable nuclease compositions and methods of use thereof
#4325Method for confirming introduction of foreign gene into cells and method for manufacturing introduction foreign gene into cells
#4326Method of inactivating a glucocorticoid receptor gene in an isolated cell
#4327TARGETED GENE ACTIVATION USING MODIFIED GUIDE RNA
#4328DESIGNING SENSITIVE, SPECIFIC, AND OPTIMALLY ACTIVE BINDING MOLECULES FOR DIAGNOSTICS AND THERAPEUTICS
#4329METHOD FOR THE ISOLATION OF INTACT EXTRACELLULAR VESICLES
#4330Engineered cascade components and cascade complexes
#4331Multiplexed genome editing
#4332Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
#4333Platform for expressing protein of interest in liver
#4334REPEAT-MEDIATED PLANT SITE-SPECIFIC RECOMBINATION METHOD
#4335Trans-activated functional RNA by strand displacement and uses thereof
#4336MODULATION OF MICROBIOTA COMPOSITIONS USING TARGETED NUCLEASES
#4337System and method for genome editing
#4338Method For Isolating DNA By Using Cas Protein System
#4339Dynamically-adaptive live therapeutic agents and methods of use thereof
#4340ENGINEERED GUT MICROBES AND USES THEREOF
#4341CRISPR/CAS-ADENINE DEAMINASE BASED COMPOSITIONS, SYSTEMS, AND METHODS FOR TARGETED NUCLEIC ACID EDITING
#4342METHODS AND COMPOSITIONS FOR NUCLEIC ACID DETECTION
#4343Programmable DNA-guided artificial restriction enzymes
#4344Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4345METHODS AND COMPOSITIONS FOR HOMOLOGY-DIRECTED REPAIR OF CAS ENDONUCLEASE MEDIATED DOUBLE STRAND BREAKS
#4346Modified aminoacyl-tRNA synthetase and use thereof
#4347Modified Guide RNAs for Gene Editing
#4348Methods and compositions for targeted genomic insertion
#4349Method for inducing exon skipping by genome editing
#4350His-MBP tagged DNA endonuclease for facilitated enzyme removal
#4351Compositions and Methods for Inducing Protein Function
#4352RECOMBINANT ORGANISMS AND METHODS FOR PRODUCING GLYCOMOLECULES WITH LOW SULFATION
#4353Compositions of and methods for in vitro viral genome engineering
#4354ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF
#4355Method for inducing a tolerogenic immune response
#4356Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy
#4357COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TET2 ENGINEERED T CELL THERAPY
#4358Materials and methods for engineering cells and uses thereof in immuno-oncology
#4359Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4360CRISPR-BASED GENOME MODIFICATION AND REGULATION
#4361CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#4362ENGINEERED DCAS9 WITH REDUCED TOXICITY AND ITS USE IN GENETIC CIRCUITS
#4363TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS DELIVERED BY LIPID NANOPARTICLES
#4364GUIDE RNA WITH CHEMICAL MODIFICATIONS
#4365SCREENING AND APPLICATION OF SGRNA FOR AHI1 GENE EDITING
#4366CLEAVAGE-RESISTANT DONOR NUCLEIC ACIDS AND METHODS OF USE
#4367Near-infrared photothermally activated CRISPR/CAS9 genome editing machine
#4368CRISPR-associated (CAS) protein
#4369CAS12A SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING
#4370VIRAL VECTOR PRODUCTION SYSTEM
#4371GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
#4372Sequence-specific in vivo cell targeting
#4373Double knockout (GT/CMAH-KO) pigs, organs and tissues
#4374Biomarkers predictive of anti-immune checkpoint response
#4375Methods for immunoregulation by modulating plasminogen-apple-nematode (PAN) domain-containing proteins
#4376METHODS FOR IDENTIFICATION OF GENES AND GENETIC VARIANTS FOR COMPLEX PHENOTYPES USING SINGLE CELL ATLASES AND USES OF THE GENES AND VARIANTS THEREOF
#4377PLANTS WITH ENHANCED RESISTANCE TO BACTERIAL PATHOGENS
#4378Compositions and methods for immunooncology
#4379Mobile-CRISPRi plasmids and related methods
#4380Targeted trans-splicing using CRISPR/Cas13
#4381CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC)
#4382Barcode-based nucleic acid sequence assembly
#4383CAS12B SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING
#4384TUNING MICROBIAL POPULATIONS WITH PROGRAMMABLE NUCLEASES
#4385Type VI CRISPR orthologs and systems
#4386Gene-regulating compositions and methods for improved immunotherapy
#4387GENE REGULATION VIA CONDITIONAL NUCLEAR LOCALIZATION OF GENE MODULATING POLYPEPTIDES
#4388Methods and compositions for RNA-guided treatment of HIV infection
#4389EXTRACHROMOSOMAL DNA LABELING
#4390Chimeric proteins and methods of regulating gene expression
#4391Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4392Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4393Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4394Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4395Methods for producing a complex transgenic trait locus
#4396CAS9 mutant genes and polypeptides encoded by same
#4397SITE-SPECIFIC ENZYMES AND METHODS OF USE
#4398Modified protein and method for altering genome of cell
#4399Recombinogenic nucleic acid strands in situ
#4400MODULATION OF LIVER GENES
#4401Sequence specific antimicrobials
#4402Sequence specific antimicrobials
#4403Methods and compositions for treating cancer
#4404DNA-PK inhibitors
#4405Mutant plant or cell with reduced XylT and FucT
#4406CAS9 proteins including ligand-dependent inteins
#4407RIBONUCLEOPROTEIN TRANSFECTION AGENTS
#4408GENOME EDITING IN PLANTS
#4409TRANSFORMATION OF DICOT PLANTS
#4410Gene targeting in plants using DNA viruses
#4411Recombinant cell and preparation process and use thereof
#4412Expression of FOXP3 in edited CD34+ cells
#4413METHODS OF INACTIVATING GENE EDITING MACHINERIES
#4414Conjugates of Guide RNA-Cas Protein Complex
#4415METHODS AND COMPOSITIONS FOR TREATING ANGELMAN SYNDROME
#4416Chimeric genome engineering molecules and methods
#4417RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES
#4418RNA-programmable endonuclease systems and uses thereof
#4419Tale RVD specifically recognizing DNA base modified by methylation and application thereof
#4420Methods and compositions for RNA-guided treatment of HIV infection
#4421Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
#4422METHOD OF PRODUCING LEUKOCYTES USING PTPN2 INHIBITION FOR ADOPTIVE CELL TRANSFER
#4423Determination of base modifications of nucleic acids
#4424SYSTEM AND METHOD FOR INDUCING CLUSTERS OF GENE REGULATORY PROTEINS TARGETED TO SPECIFIC GENOMIC LOCI
#4425RNA-TARGETING FUSION PROTEIN COMPOSITIONS AND METHODS FOR USE
#4426COMPOSITIONS AND METHODS FOR REGULATING A BIOLOGICAL PROCESS
#4427CRISPR/CAS ALL-IN-TWO VECTOR SYSTEMS FOR TREATMENT OF DMD
#4428COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF
#4429COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF
#4430Method for genome editing using a self-inactivating CRISPR nuclease
#4431SELECTION METHODS
#4432Targeting BCL11A distal regulatory elements with a CAS9-CAS9 fusion for fetal hemoglobin reinduction
#4433CRISPR-BASED DOWNREGULATION OF ALPHA-SYNUCLEIN EXPRESSION AS A NOVEL PARKINSON'S DISEASE THERAPEUTIC
#4434CRISPR KNOCK-OUT OF THE ALPHA-SYNUCLEIN TRIPLICATION MODEL OF PARKINSON'S DISEASE
#4435Customized class switch of immunoglobulin genes in lymphoma and hybridoma by CRISPR/CAS9 technology
#4436LENTIVIRAL-BASED VECTORS AND RELATED SYSTEMS AND METHODS FOR EUKARYOTIC GENE EDITING
#4437NOVEL CRISPR ENZYMES AND SYSTEMS
#4438CRISPR-RELATED METHODS AND COMPOSITIONS
#4439Method for increasing efficiency of homologous recombination-based gene editing in plant
#4440Curing for recursive nucleic acid-guided cell editing
#4441Detergent composition
#4442DNase therapy for intravascular accumulation of extracellular DNA
#4443Genetic correction of mutated genes
#4444DNA mapping and sequencing on linearized DNA molecules
#4445ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
#4446RNA-GUIDED GENE EDITING AND GENE REGULATION
#4447SELF-INACTIVATING (SIN) CRISPR/CAS OR CRISPR/CPF1 SYSTEMS AND USES THEREOF
#4448EXTENDED SINGLE GUIDE RNA AND USE THEREOF
#4449Simultaneous multiplex genome editing in yeast
#4450CRISPR/Cas9 Systems, and Methods of Use Thereof
#4451Angiogenin expression in plants
#4452Single cell chromatin immunoprecipitation sequencing assay
#4453ENGINEERED TARGET SPECIFIC NUCLEASES
#4454ENGINEERED TARGET SPECIFIC NUCLEASES
#4455THE FATTY ACID DESATURASE 2 FAMILY IN TOMATO
#4456Compositions and methods for modifying genomes
#4457METHOD FOR INDUCING RNA SILENCING
#4458Using nucleosome interacting protein domains to enhance targeted genome modification
#4459NUCLEIC ACID-BASED THERAPEUTICS
#4460Complex for genome editing having stability and few side-effects, and nucleic acid coding same
#4461RNA preparations comprising purified modified RNA for reprogramming cells
#4462ANTIBODY GENE EDITING IN B LYMPHOCYTES
#4463NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
#4464TALE-NUCLEASES FOR ALLELE-SPECIFIC CODON MODIFICATION AND MULTIPLEXING
#4465RNA-guided endonuclease expressing algal strain for high efficiency in vivo genome editing
#4466Systems, methods and composition of using RNase III mutants to produce sRNA to control host pathogen infection
#4467Modified tracrRNAs gRNAs, and uses thereof
#4468METHODS OF MULTIPLEXING CRISPR
#4469Gene Editing for Autosomal Dominant Diseases
#4470CasZ compositions and methods of use
#4471METHODS AND COMPOSITIONS FOR SEQUENCES GUIDING CAS9 TARGETING
#4472Optimized protein linkers and methods of use
#4473T CELLS EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS
#4474METHODS AND REAGENTS FOR ENRICHMENT OF NUCLEIC ACID MATERIAL FOR SEQUENCING APPLICATIONS AND OTHER NUCLEIC ACID MATERIAL INTERROGATIONS
#4475ENRICHMENT OF NUCLEIC ACIDS
#4476LENTIVIRAL VECTORS FOR HIGH-TITER TRANSDUCTION OF PRIMARY HUMAN CELLS
#4477NOVEL NUCLEIC ACID CONSTRUCT
#4478Modulating lactogenic activity in mammalian cells
#4479Systems, methods, and compositions for targeted nucleic acid editing
#4480Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection
#4481Compositions for linking DNA-binding domains and cleavage domains
#4482Systems methods, and compositions for targeted nucleic acid editing
#4483Methods and products for transfecting cells
#4484Bacterial colicin-immunity protein protein purification system
#4485METHODS AND COMPOSITIONS FOR IMPROVED HOMOLOGY DIRECTED REPAIR
#4486Identification of white leghorns red plumage mutagenic mutant genotype and cultivation method for supporting system of red plumage pink shell layer chickens
#4487GENETIC MODIFICATION OF MITOCHONDRIAL GENOMES
#4488RNA-GUIDED GENE EDITING AND GENE REGULATION
#4489METHODS FOR NON-TRANSGENIC GENOME EDITING IN PLANTS
#4490CRISPR/Cas9 vector combination and application thereof in gene knockout
#4491DNMT3B GENE-DEFICIENT CHO CELL LINE, PREPARATION AND APPLICATIONS THEREOF AND RECOMBINANT PROTEIN EXPRESSION SYSTEM USING THE SAME
#4492Methods of treating cancer by inhibiting SETD2
#4493Automated cell processing methods, modules, instruments, and systems
#4494Methods for identifying selective binding pairs
#4495Engineered cascade components and cascade complexes
#4496CTLA4 HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE
#4497MODIFIED LYMPHOCYTES
#4498Nucleic acid products and methods of administration thereof
#4499TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES
#4500Split Trans-Complementing Gene-Drive System for Suppressing Aedes Aegypti Mosquitos